Charles Burger, MD
Pulmonary Disease · Jacksonville, FLNPI 1790772671
Payments from drug & device makers
Across 432 payments — averaging $12,899 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$4.7M
- United Therapeutics Corporation$437K
- Insmed, Inc.$171K
- Sumitomo Pharma America, Inc.$106K
- Actelion Pharmaceuticals, Ltd$88K
- Janssen Research & Development, LLC$56K
- plus $58K from 8 others
Across 6 payments — averaging $323.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Insmed, Inc.$1K
- United Therapeutics Corporation$554
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 70 | $4,656,704 |
| United Therapeutics Corporation | 199 | $436,997 |
| Insmed, Inc. | 32 | $170,940 |
| Sumitomo Pharma America, Inc. | 18 | $106,182 |
| Actelion Pharmaceuticals, Ltd | 24 | $87,884 |
| Janssen Research & Development, LLC | 15 | $55,716 |
| Actelion Pharmaceuticals US, Inc. | 59 | $33,007 |
| Acceleron Pharma, Inc. | 2 | $14,040 |
| Janssen Scientific Affairs, LLC | 6 | $8,524 |
| Bayer | 2 | $2,100 |
| Chiesi USA, Inc. | 1 | $110 |
| Johnson & Johnson | 1 | $77 |
| Sandoz | 2 | $74 |
| Philips North America LLC | 1 | $19 |
How this compares
$5,572,374 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Jacksonville
- Abubakr BajwaJacksonville$1.4M
- Jennifer FultonJacksonville$791K
- Sebastian Fernandez-BussyJacksonville$559K
- Remzi BagJacksonville$556K
- Jose Soto SotoJacksonville$549K
- Augustine LeeJacksonville$533K
- Jorge MalleaJacksonville$478K
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
- Carlos MartinezHomestead$9.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.